Infectious Diseases

Courtagen To Partner With Tetracore In Biodefense Initiative

10 Feb 2012

Courtagen Life Sciences, Inc. ("Courtagen"), a privately held life sciences company that provides innovative proteomic and genomic products and services to the life sciences industry, recently announced that it has entered into a strategic collaboration with Tetracore, Inc. ("Tetracore") to develop a next generation biothreat assay for identifying and diagnosing high priority biological agents ...

Inequality affecting health

9 Feb 2012

Infectious diseases associated with child poverty and overcrowding are approaching a peak not seen since the epidemic of meningococcal disease a decade ago. read more

Press Release

9 Feb 2012

PaxVax Corporation, developer of innovative and socially responsible oral vaccines against infectious diseases, announced the expansion of its executive management team with the appointments of Nima Farzan as Executive Vice President and Chief Operating Officer, Thomas P. Monath, M.D. as Chief Technology Officer, and Jonathan F. Smith, Ph.D. as Executive Vice President and Chief Scientific ...